Elliott Investment Management has established a major stake in Catalent and is urging for a shake-up on the company’s board, the Wall Street Journal’s Lauren Thomas reports. The activist investor has been in talks with potential director candidates about joining a slate of nominees to run in a proxy contest, the author says, citing people familiar with the matter. The exact size of the stake could not be learned, the author notes.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CTLT:
- Catalent Stock (NYSE:CTLT) Soars; Activist Elliott Snaps Up Big Stake
- Regeneron 483 issues might not require reinspection, says Morgan Stanley
- Catalent assumed with a Neutral at JPMorgan
- Catalent put volume heavy and directionally bearish
- REGN, CTLT Continue Sliding Following FDA Rejection of Eylea Drug